BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Inveresk Research (Incorporating CTBR) (IRGI) Announces First Quarter 2004 Earnings Release And Webcast


10/19/2005 5:10:44 PM

Conference Call on Wednesday, May 5, 2004 at 10:00 a.m. EDT

CARY, N.C--(BUSINESS WIRE)--April 7, 2004--Inveresk Research Group, Inc. (Nasdaq:IRGI - News) will be announcing its first quarter earnings results for the fiscal period ended March 31, 2004, after the market closes on Tuesday, May 4, 2004. Management of the company will host a conference call to discuss these results on Wednesday, May 5, 2004, at 10:00 a.m. Eastern Daylight Time. Presenting from the company will be Walter Nimmo, President and Chief Executive Officer and Paul Cowan, Chief Financial Officer.

The conference call will be webcast live and will also be available for replay two hours after the completion of the call until 5:00 p.m. EDT on Tuesday, May 11, 2004. The call is being webcast by CCBN and can be accessed at Inveresk's web site at www.inveresk.com

The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password-protected event management site, StreetEvents (www.streetevents.com).

Inveresk Research is a leading provider of drug development services to companies in the pharmaceutical and biotechnology industries. Through its pre-clinical and clinical business segments, the Company offers a broad range of drug development services, including pre-clinical safety and pharmacology evaluation services, laboratory sciences services and clinical development services. Inveresk Research is one of a small number of drug development services companies currently providing a comprehensive range of pre-clinical and clinical development services on a worldwide basis. The Company's client base includes major pharmaceutical companies in North America, Europe and Japan, as well as many biotechnology and specialty pharmaceutical companies. For more information on Inveresk Research, visit the Company's web site at http://www.inveresk.com.

Contact:

Financial Dynamics Matt Dallas, 212-850-5627 mdallas@fd-us.com

Source: Inveresk Research Group, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES